Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 88: | Line 88: | ||
| | | | ||
|- | |- | ||
| Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| | | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden | ||
| | |FQR | ||
|Complete | |||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| | | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff | ||
| | |FQR | ||
|PENDING | |||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| | | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding | ||
| | |FQR | ||
|Complete | |||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| | | Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Sarah Rapisardo | ||
| | |FQR | ||
|PENDING | |||
| | | | ||
| | | | ||